Corrigendum to "Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity" [Mol. Immunol. 60, (2014), 135-142], DOI:10.1016/j.molimm.2014.04.006;Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity

Molecular Immunology

Volumn 60, Issue 2, 2014, Pages 135-142

  Yen, Jia Hau ^a   Yang, Deng Jye ^b   Chen, Meng Chi ^a   Yi Ying, Wu ^c   Hsieh, Yu Fan ^a   Cheng, Yueh Mei ^a   Huang, Wen Nan ^d   Szondy, Zsuzsa ^e   Tsay, Gregory J ^a,f  

^a Institute of Microbiology and Immunology   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^f CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Daidzein; Efferocytosis; Erk; Mitochondrial membrane potential; Rac1

Indexed keywords

DAIDZEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN CDC42; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; RAC1 PROTEIN; SMALL INTERFERING RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ASSAY; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; DENSITY GRADIENT CENTRIFUGATION; EFFEROCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MACROPHAGE; MEMBRANE BIOLOGY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; NONHUMAN; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

DAIDZEIN; EFFEROCYTOSIS; ERK; MITOCHONDRIAL MEMBRANE POTENTIAL; RAC1;

ANIMALS; CELL LINE; GTP-BINDING PROTEINS; HUMANS; ISOFLAVONES; MAP KINASE SIGNALING SYSTEM; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; PHAGOCYTOSIS; PHOSPHORYLATION; RAC1 GTP-BINDING PROTEIN; TRANSGLUTAMINASES; UP-REGULATION;

EID: 84901032851     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.07.001     Document Type: Erratum

References (43)

1. Anne De Wilde A., Heberden C., Chaumaz G., Bordat C., Lieberherr M. Signaling networks from Gbeta1 subunit to transcription factors and actin remodeling via a membrane-located ER beta-related protein in the rapid action of daidzein in osteoblasts. J. Cell. Physiol. 2006, 209:786-801.
2. Antonyak M.A., McNeill C.J., Wakshlag J.J., Boehm J.E., Cerione R.A. Activation of the Ras-ERK pathway inhibits retinoic acid-induced stimulation of tissue transglutaminase expression in NIH3T3 cells. J. Biol. Chem. 2003, 278:15859-15866.
3. Baumann I., Kolowos W., Voll R.E., Manger B., Gaipl U., Neuhuber W.L., Kirchner T., Kalden J.R., Herrmann M. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum. 2002, 46:191-201.
4. Bosch X. Systemic lupus erythematosus and the neutrophil. N. Eng. J. Med. 2011, 365:758-760.
5. Brugnera E., Haney L., Grimsley C., Lu M., Walk S.F., Tosello-Tampont A.C., Macara I.G., Madhani H., Fink G.R., Ravichandran K.S. Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex. Nat. Cell Biol. 2002, 4:74-582.
6. David-Pfeuty T., Bagrodia S., Shalloway D. Differential localization patterns of myristoylated and nonmyristoylated c-Src proteins in interphase and mitotic c-Src overexpresser cells. J. Cell Sci. 1993, 105(Pt 3):613-628.
7. Fesus L., Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem. Sci. 2002, 27:534-539.
8. Filardy A.A., Pires D.R., Nunes M.P., Takiya C.M., Freire-de-Lima C.G., Ribeiro-Gomes F.L., DosReis G.A. Proinflammatory clearance of apoptotic neutrophils induces an IL-12(low)IL-10(high) regulatory phenotype in macrophages. J. Immunol. 2010, 185:2044-2050.
9. Firestein G.S., Yeo M., Zvaifler N.J. Apoptosis in rheumatoid arthritis synovium. J. Clin. Invest. 1995, 96:1631-1638.
10. Flinder L.I., Timofeeva O.A., Rosseland C.M., Wierod L., Huitfeldt H.S., Skarpen E. EGF-induced ERK-activation downstream of FAK requires rac1-NADPH oxidase. J. Cell. Physiol. 2011, 226:2267-2278.
11. Franke A.A., Custer L.J., Wang W., Shi C.Y. HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc. Soc. Exp. Biol. Med. (New York, N.Y) 1998, 217:263-273.
12. Garcia Palacios V., Robinson L.J., Borysenko C.W., Lehmann T., Kalla S.E., Blair H.C. Negative regulation of RANKL-induced osteoclastic differentiation in RAW264.7 Cells by estrogen and phytoestrogens. J. Biol. Chem. 2005, 280:13720-13727.
13. Gumienny T.L., Brugnera E., Tosello-Trampont A.C., Kinchen J.M., Haney L.B., Nishiwaki K., Walk S.F., Nemergut M.E., Macara I.G., Francis R., Schedl T., Qin Y., Van Aelst L., Hengartner M.O., Ravichandran K.S. CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell 2001, 107:27-41.
14. Hamalainen M., Nieminen R., Vuorela P., Heinonen M., Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediat. Inflamm. 2007, 2007:45673.
15. Henson P.M., Hume D.A. Apoptotic cell removal in development and tissue homeostasis. Trends Immunol. 2006, 27:244-250.
16. Henson P.M., Bratton D.L., Fadok V.A. Apoptotic cell removal. Curr. Biol. 2001, 11:R795-R805.
17. Hodge S., Hodge G., Scicchitano R., Reynolds P.N., Holmes M. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol. Cell Biol. 2003, 81:289-296.
18. Kang S.K., Lee J.Y., Chung T.W., Kim C.H. Overexpression of transglutaminase 2 accelerates the erythroid differentiation of human chronic myelogenous leukemia K562 cell line through PI3K/Akt signaling pathway. FEBS Lett. 2004, 577:361-366.
19. Kim J.W., Jin Y.C., Kim Y.M., Rhie S., Kim H.J., Seo H.G., Lee J.H., Ha Y.L., Chang K.C. Daidzein administration in vivo reduces myocardial injury in a rat ischemia/reperfusion model by inhibiting NF-kappaB activation. Life Sci. 2009, 84:227-234.
20. Kress H., Stelzer E.H., Holzer D., Buss F., Griffiths G., Rohrbach A. Filopodia act as phagocytic tentacles and pull with discrete steps and a load-dependent velocity. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:11633-11638.
21. Malorni W., Farrace M.G., Matarrese P., Tinari A., Ciarlo L., Mousavi-Shafaei P., D'Eletto M., Di Giacomo G., Melino G., Palmieri L., Rodolfo C., Piacentini M. The adenine nucleotide translocator 1 acts as a type 2 transglutaminase substrate: implications for mitochondrial-dependent apoptosis. Cell Death Differ. 2009, 16:1480-1492.
22. Michlewska S., McColl A., Rossi A.G., Megson I.L., Dransfield I. Clearance of dying cells and autoimmunity. Autoimmunity 2007, 40:267-273.
23. Mitra S.K., Hanson D.A., Schlaepfer D.D. Focal adhesion kinase: in command and control of cell motility. Nat. Rev. 2005, 6:56-68.
24. Munoz L.E., Herrmann M., Gaipl U.S. An impaired detection and clearance of dying cells can lead to the development of chronic autoimmunity. Z. Rheumatol. 2005, 64:370-376.
25. Nakaya M., Kitano M., Matsuda M., Nagata S. Spatiotemporal activation of Rac1 for engulfment of apoptotic cells. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9198-9203.
26. Odaka C., Mizuochi T., Yang J., Ding A. Murine macrophages produce secretory leukocyte protease inhibitor during clearance of apoptotic cells: implications for resolution of the inflammatory response. J. Immunol. 2003, 171:1507-1514.
27. Park S.Y., Kang K.B., Thapa N., Kim S.Y., Lee S.J., Kim I.S. Requirement of adapter protein GULP-6 for stabilin-2 mediated cell corpse engulfment. J. Biol. Chem. 2008, 283:10593-10600.
28. Park D., Han C.Z., Elliott M.R., Kinchen J.M., Trampont P.C., Das S., Collins S., Lysiak J.J., Hoehn K.L., Ravichandran K.S. Continued clearance of apoptotic cells critically depends on the phagocyte Ucp2 protein. Nature 2011, 477:220-224.
29. Qiu J., Tan Y.W., Hagenston A.M., Martel M.A., Kneisel N., Skehel P.A., Wyllie D.J., Bading H., Hardingham G.E. Mitochondrial calcium uniporter Mcu controls excitotoxicity and is transcriptionally repressed by neuroprotective nuclear calcium signals. Nat. Commun. 2013, 4:2034.
30. Ravichandran K.S. Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways. Immunity 2011, 35:445-455.
31. Ray R.M., Vaidya R.J., Johnson L.R. MEK/ERK regulates adherens junctions and migration through Rac1. Cell Motil. Cytoskeleton 2007, 64:143-156.
32. Savill J., Dransfield I., Gregory C., Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2002, 2:965-975.
33. Schutters K., Kusters D.H., Chatrou M.L., Montero-Melendez T., Donners M., Deckers N.M., Krysko D.V., Vandenabeele P., Perretti M., Schurgers L.J., Reutelingsperger C.P. Cell surface-expressed phosphatidylserine as therapeutic target to enhance phagocytosis of apoptotic cells. Cell Death Differ. 2013, 20:49-56.
34. Su H.P., Nakada-Tsukui K., Tosello-Trampont A.C., Li Y., Bu G., Henson P.M., Ravichandran K.S. Interaction of CED-6/GULP, an adapter protein involved in engulfment of apoptotic cells with CED-1 and CD91/low density lipoprotein receptor-related protein (LRP). J. Biol. Chem. 2002, 277:1772-11779.
35. -/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:7812-7817.
36. -/- mouse. Adv Enzymol. Relat. Areas Mol. Biol. 2011, 78:295-345.
37. Tosello-Trampont A.C., Nakada-Tsukui K., Ravichandran K.S. Engulfment of apoptotic cells is negatively regulated by Rho-mediated signaling. J. Biol. Chem. 2003, 278:49911-49919.
38. Toth B., Garabuczi E., Sarang Z., Vereb G., Vamosi G., Aeschlimann D., Blasko B., Becsi B., Erdodi F., Lacy-Hulbert A., Zhang A., Falasca L., Birge R.B., Balajthy Z., Melino G., Fesus L., Szondy Z. Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells. J. Immunol. 2009, 182:2084-2092.
39. Vanden Berghe W., Dijsselbloem N., Vermeulen L., Ndlovu M.N., Boone E., Haegeman G. Attenuation of mitogen- and stress-activated protein kinase-1-driven nuclear factor-kappaB gene expression by soy isoflavones does not require estrogenic activity. Cancer Res. 2006, 66:4852-4862.
40. Vial E., Sahai E., Marshall C.J. ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 2003, 4:67-79.
41. Wang S.W., Chen Y., Joseph T., Hu M. Variable isoflavone content of red clover products affects intestinal disposition of biochanin A, formononetin, genistein, and daidzein. J. Altern. Complement. Med. (New York, N.Y.) 2008, 14:287-297.
42. Yen J.H., Yang D.J., Chen M.C., Hsieh Y.F., Sun Y.S., Tsay G.J. Glycine tomentella Hayata inhibits IL-1beta and IL-6 production, inhibits-9 activity, and enhances RAW264.7 macrophage clearance of apoptotic cells. J. Biomed. Sci. 2010, 17:83.
43. Yi S.J., Groffen J., Heisterkamp N. Transglutaminase 2 regulates the GTPase-activating activity of Bcr. J. Biol. Chem. 2009, 284:35645-35651.